Cytosponge
Sponsors
Mayo Clinic, University of North Carolina, Chapel Hill, Columbia University, Changhai Hospital
Conditions
Barrett EsophagusBarrett's EsophagusEosinophilic EsophagitisEsophageal AdenocarcinomaEsophageal Squamous Cell CarcinomaGERD
Unknown Phase
Cytosponge Protocol IRB 11-006429
TerminatedNCT01585103
Start: 2012-12-31End: 2016-06-07Updated: 2022-06-13
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
CompletedNCT02106910
Start: 2014-10-27End: 2018-08-14Updated: 2020-11-20
Cytosponge and Dietary Therapy in EoE
CompletedNCT02599558
Start: 2015-11-30End: 2022-01-08Updated: 2022-12-30
Short Duration 6Fed Sponge For EoE Patients
WithdrawnNCT03354221
Start: 2017-08-31End: 2019-03-15Updated: 2020-01-27
Rapid Assessment of Esophageal Adenocarcinoma Risk Test
TerminatedNCT03366012
Start: 2018-08-01End: 2023-05-19Updated: 2024-11-08
Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus
CompletedNCT04301986
Start: 2020-08-11End: 2022-05-10Updated: 2023-05-08
Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma
Enrolling by invitationNCT06429865
Start: 2024-05-31End: 2024-12-31Target: 1000Updated: 2024-05-28